Literature DB >> 34842232

Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells.

Shuhan Meng1, Aaron G Whitt2, Allison Tu3, John W Eaton2, Chi Li4, Kavitha Yaddanapudi5.   

Abstract

Embryonic stem cells (ESCs) are pluripotent stem cells capable of self-renewal and differentiation into all types of embryonic cells. Like many other cell types, ESCs release small membrane vesicles, such as exosomes, to the extracellular environment. Exosomes serve as essential mediators of intercellular communication and play a basic role in many (patho)physiological processes. Granulocyte-macrophage colony-stimulating factor (GM-CSF) functions as a cytokine to modulate the immune response. The presence of GM-CSF in exosomes has the potential to boost their immune-regulatory function. Here, GM-CSF was stably overexpressed in the murine ESC cell line ES-D3. A protocol was developed to isolate high-quality exosome-enriched extracellular vesicles (EVs) from ES-D3 cells overexpressing GM-CSF. Isolated exosome-enriched EVs were characterized by a variety of experimental approaches. Importantly, significant amounts of GM-CSF were found to be present in exosome-enriched EVs. Overall, GM-CSF-bearing exosome-enriched EVs from ESCs might function as cell-free vesicles to exert their immune-regulatory activities.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34842232      PMCID: PMC9127305          DOI: 10.3791/60170

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.424


  28 in total

1.  Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications.

Authors:  Brian Dalby; Sharon Cates; Adam Harris; Elise C Ohki; Mary L Tilkins; Paul J Price; Valentina C Ciccarone
Journal:  Methods       Date:  2004-06       Impact factor: 3.608

Review 2.  Therapeutic and diagnostic applications of extracellular vesicles.

Authors:  Stephan Stremersch; Stefaan C De Smedt; Koen Raemdonck
Journal:  J Control Release       Date:  2016-08-02       Impact factor: 9.776

3.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Authors:  G Dranoff; E Jaffee; A Lazenby; P Golumbek; H Levitsky; K Brose; V Jackson; H Hamada; D Pardoll; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 4.  GM-CSF-based cancer vaccines.

Authors:  Glenn Dranoff
Journal:  Immunol Rev       Date:  2002-10       Impact factor: 12.988

Review 5.  GM-CSF in the generation of dendritic cells from human blood monocyte precursors: recent advances.

Authors:  Lucia Conti; Sandra Gessani
Journal:  Immunobiology       Date:  2008-09-02       Impact factor: 3.144

Review 6.  The Dichotomy of Tumor Exosomes (TEX) in Cancer Immunity: Is It All in the ConTEXt?

Authors:  Katherine E Kunigelis; Michael W Graner
Journal:  Vaccines (Basel)       Date:  2015-12-17

Review 7.  Stem cell therapy in neurodegenerative diseases: From principles to practice.

Authors:  Rajalingham Sakthiswary; Azman Ali Raymond
Journal:  Neural Regen Res       Date:  2012-08-15       Impact factor: 5.135

Review 8.  Exosomes for Immunoregulation and Therapeutic Intervention in Cancer.

Authors:  Xuan Zhang; Zenglin Pei; Jinyun Chen; Chunxia Ji; Jianqing Xu; Xiaoyan Zhang; Jin Wang
Journal:  J Cancer       Date:  2016-05-25       Impact factor: 4.207

Review 9.  Recent advancements in the use of exosomes as drug delivery systems.

Authors:  Edwin J Bunggulawa; Wei Wang; Tieying Yin; Nan Wang; Colm Durkan; Yazhou Wang; Guixue Wang
Journal:  J Nanobiotechnology       Date:  2018-10-16       Impact factor: 10.435

10.  Effects of Feeder Cell Types on Culture of Mouse Embryonic Stem Cell In Vitro.

Authors:  Yun-Gwi Park; Seung-Eun Lee; Eun-Young Kim; Hyuk Hyun; Min-Young Shin; Yeo-Jin Son; Su-Young Kim; Se-Pill Park
Journal:  Dev Reprod       Date:  2015-09
View more
  1 in total

1.  Biocompatible exosome-modified fibrin gel accelerates the recovery of spinal cord injury by VGF-mediated oligodendrogenesis.

Authors:  Xiaolie He; Li Yang; Kun Dong; Feng Zhang; Yuchen Liu; Bei Ma; Youwei Chen; Jian Hai; Rongrong Zhu; Liming Cheng
Journal:  J Nanobiotechnology       Date:  2022-08-02       Impact factor: 9.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.